SWAV NASDAQ
ShockWave Medical, Inc.
1W: +0.2%
1M: +1.4%
3M: +28.3%
1Y: +21.2%
3Y: +90.6%
5Y: +448.7%
$334.75
Last traded 2024-05-30 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$12.6B
52W Range157.0-334.9
Volume3,947,054
Avg Volume1,301,576
Beta0.88
Dividend—
Analyst Ratings
Company Info
CEODouglas E. Godshall
Employees1,468
SectorHealthcare
IndustryMedical - Devices
IPO Date2019-03-07
Websiteshockwavemedical.com
5403 Betsy Ross Drive
Santa Clara, CA 95054
US
Santa Clara, CA 95054
US
510 279 4262
About ShockWave Medical, Inc.
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Zacharias Isaac | D-Return | 29,588 | — | 2024-05-31 |
| Godshall Douglas Eva | D-Return | 100,810 | — | 2024-05-31 |
| FRANCIS LAURA | D-Return | 13,690 | $6.59 | 2024-05-31 |
| MOLL FREDERIC H | D-Return | 17,381 | $17.00 | 2024-05-31 |
| WATKINS FRANK T | D-Return | 84,313 | $3.42 | 2024-05-31 |